Labor pain relief with remifentanil

Comparison of analgesic effect of remifentanil with and without dexamethasone in labor

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150808023559N16

Enrollment

100

Registered

2018-03-10

Start date

2018-04-19

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain. Delivery

Interventions

Intervention 1: Intervention group: Intravenous Remifentanil 0/05 µg/kg/min (Tofigh Daru Co.) and 8 mg intravenous Dexamethasone (once, 2 cc, Irandaroo Co.) injection. Intervention 2: Control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Over 37 weeks pregnancy First or second pregnancy Singleton

Exclusion criteria

Exclusion criteria: Malpresentation of fetus Macrosomia

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before analgesic administrations and two times (30 and 60 min) after intervention. Method of measurement: Visual analog scale.	—

Secondary

Measure	Time frame
Apgar. Timepoint: 1 and 5 minutes after birth. Method of measurement: Apgar test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaieh Sagafi rad

Ardabil University of Medical Sciences

drssrad62@gmail.com+98 45 4233 8888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026